PHARMACEUTICAL COMPOSITION, CONTAINING NM23 ACTIVATOR, FOR INHIBITING CANCER METASTASIS
申请人:Ewha University-Industry Collaboration Foundation
公开号:EP3616692A1
公开(公告)日:2020-03-04
The present disclosure relates to a pharmaceutical composition for suppressing cancer metastasis containing, as an active ingredient, an activator compound of the cancer metastasis inhibitor Nm23, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound according to the present disclosure may suppress the metastasis of cancer cells by promoting the activity of Nm23 associated with cancer metastasis, and thus may be useful as a pharmaceutical composition for suppressing cancer metastasis.
本公开涉及一种用于抑制癌症转移的药物组合物,该组合物含有作为活性成分的癌症转移抑制剂Nm23的活化剂化合物、其立体异构体或其药学上可接受的盐。根据本公开的化合物可通过促进与癌症转移相关的 Nm23 的活性来抑制癌细胞的转移,因此可用作抑制癌症转移的药物组合物。